Vitas-M small molecule compound
2-({[(3Z,8xi,9xi,14xi)-17-hydroxy-20-oxopregn-4-en-3-ylidene]amino}oxy)-N-[2-(1H-imidazol-4-yl)ethyl]acetamide
Catalog ID
STL524433
SMILES C[C@@]12CC/C(=N/OCC(=O)NCCc3c[nH]cn3)/C=C2CCC2C1CC[C@]1(C2CC[C@]1(O)C(=O)C)C
Contact us by email for worldwide delivery information, pricing, and real‑time availability. Send us your quotation request, and we will confirm stock levels, provide exact costs and lead times, suggest alternatives or find analogs when helpful, and share any additional specifications you may need.
We supply compounds in quantities from 1 mg up to 5 g for research and development purposes only.
We do not supply quantities above 5 g.
Structure and other identifiers
2D representation rendered from the SMILES, with core physicochemical data.Formula C28H40N4O4 MW 496.65 g/mol Purity >90% as per NMR
InChI
InChI=1S/C28H40N4O4/c1-18(33)28(35)12-8-24-22-5-4-19-14-20(6-10-26(19,2)23(22)7-11-27(24,28)3)32-36-16-25(34)30-13-9-21-15-29-17-31-21/h14-15,17,22-24,35H,4-13,16H2,1-3H3,(H,29,31)(H,30,34)/b32-20-/t22?,23?,24?,26-,27-,28-/m0/s1InChIKey
OTISSVUPJCZLPE-HZIAHAQGSA-NSynonyms
16396871
2((((3Z8xi9xi14xi)17hydroxy20oxopregn4en3ylidene)amino)oxy)N(2(1Himidazol4yl)ethyl)acetamide
2((~(Z))((10~(R)13~(S)17~(R))17acetyl17hydroxy1013dimethyl267891112141516decahydro1~(H)cyclopenta(a)phenanthren3ylidene)amino)oxy~(N)(2(1~(H)imidazol5yl)ethyl)acetamide
C(C@@)12CCC(=NOCC(=O)NCCc3c(nH)cn3)C=C2CCC2C1CC(C@)1(C2CC(C@)1(O)C(=O)C)C
InChI=1SC28H40N4O4c118(33)28(35)128242254191420(61026(192)23(22)71127(2428)3)32361625(34)30139211529173121h141517222435H41316H213H3(H2931)(H3034)b3220t22?23?24?262728m0s1
MFCD02114917
N(2(1Himidazol4yl)ethyl)2((((10R13S17R)17acetyl17hydroxy1013dimethyl78911121314151617decahydro1Hcyclopenta(a)phenanthren3(2H6H10H)ylidene)amino)oxy)acetamide
ZINC000008740295
ZINC000257372861
Check stock
See real-time availability and sample size for STL524433 on the Vitas-M platform.
Check stock on Vitas-MAvailable files
Download the SDF, MOL, 3D structure and SDS documents from Vitas-M.